Hyperinsulinism-hyperammonemia syndrome explained
|
Synonyms: | HI/HA or HHS |
Causes: | mutations of the GLUD1 gene |
Hyperinsulinism-hyperammonemia syndrome (HI/HA) is an autosomal dominant disorder that results in the excess production of insulin and ammonia in mammals.[1] HI/HA is caused by increased Glutamate dehydrogenase 1 (GDH) activity due to the presence of overactivating point mutations in GDH. These point mutations either directly or indirectly prevent guanosine triphosphate (GTP) binding and inhibition of GDH, which causes GDH to uncontrollably remain active.[2]
External links
Notes and References
- Pinney. SE. MacMullen. C. Becker. S. Lin. YW. Hanna. C. Thornton. P. Ganguly. A. Shyng. SL. Stanley. CA. Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations.. The Journal of Clinical Investigation. August 2008. 118. 8. 2877–86. 10.1172/JCI35414. 18596924. 2441858.
- Smith. Hong Q.. Smith. Thomas J.. Identification of a Novel Activator of Mammalian Glutamate Dehydrogenase. Biochemistry. 2016. 55. 47. 6568–6576. 10.1021/acs.biochem.6b00979. 27808506.